3-[2-oxo-2-[4-(2-sulfamoylphenyl)phenyl]ethyl]benzimidazole-5-carboximidamide
C22H19N5O3S — CID 10526785
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[2-oxo-2-[4-(2-sulfamoylphenyl)phenyl]ethyl]benzimidazole-5-carboximidamide
3-[2-oxo-2-[4-(2-sulfamoylphenyl)phenyl]ethyl]benzimidazole-5-carboximidamide (PubChem CID 10526785) has the molecular formula C22H19N5O3S and a molecular weight of 433.49 g/mol. Its IUPAC name is 3-[2-oxo-2-[4-(2-sulfamoylphenyl)phenyl]ethyl]benzimidazole-5-carboximidamide.
Molecular Properties
| Compound Name | 3-[2-oxo-2-[4-(2-sulfamoylphenyl)phenyl]ethyl]benzimidazole-5-carboximidamide |
|---|---|
| PubChem CID | 10526785 |
| Molecular Formula | C22H19N5O3S |
| Molecular Weight | 433.49 g/mol |
| Exact Mass | 433.12 |
| IUPAC Name | 3-[2-oxo-2-[4-(2-sulfamoylphenyl)phenyl]ethyl]benzimidazole-5-carboximidamide |
| SMILES | [H]/N=C(\N)c1ccc2ncn(CC(=O)c3ccc(-c4ccccc4S(N)(=O)=O)cc3)c2c1 |
| InChI | InChI=1S/C22H19N5O3S/c23-22(24)16-9-10-18-19(11-16)27(13-26-18)12-20(28)15-7-5-14(6-8-15)17-3-1-2-4-21(17)31(25,29)30/h1-11,13H,12H2,(H3,23,24)(H2,25,29,30) |
| InChIKey | QYRMEAOJLGMWNK-UHFFFAOYSA-N |
| XLogP | 2.52 |
| TPSA | 144.92 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 433.49 |
| LogP ≤ 5 | 2.52 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 10526785 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.